Elimination of SARS-CoV-2 along wastewater and sludge treatment processes.


Journal

Water research
ISSN: 1879-2448
Titre abrégé: Water Res
Pays: England
ID NLM: 0105072

Informations de publication

Date de publication:
01 Sep 2021
Historique:
received: 26 02 2021
revised: 26 06 2021
accepted: 09 07 2021
pubmed: 31 7 2021
medline: 7 9 2021
entrez: 30 7 2021
Statut: ppublish

Résumé

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is shed in the feces of infected people. As a consequence, genomic RNA of the virus can be detected in wastewater. Although the presence of viral RNA does not inform on the infectivity of the virus, this presence of genetic material raised the question of the effectiveness of treatment processes in reducing the virus in wastewater and sludge. In this work, treatment lines of 16 wastewater treatment plants were monitored to evaluate the removal of SARS-CoV-2 RNA in raw, processed waters and sludge, from March to May 2020. Viral RNA copies were enumerated using reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) in 5 different laboratories. These laboratories participated in proficiency testing scheme and their results demonstrated the reliability and comparability of the results obtained for each one. SARS-CoV-2 RNA was found in 50.5% of the 101 influent wastewater samples characterized. Positive results were detected more frequently in those regions with a COVID-19 incidence higher than 100 cases per 100,000 inhabitants. Wastewater treatment plants (WWTPs) significantly reduced the occurrence of virus RNA along the water treatment lines. Secondary treatment effluents showed an occurrence of SARS-CoV-2 RNA in 23.3% of the samples and no positive results were found after MBR and chlorination. Non-treated sludge (from primary and secondary treatments) presented a higher occurrence of SARS-CoV-2 RNA than the corresponding water samples, demonstrating the affinity of virus particles for solids. Furthermore, SARS-CoV-2 RNA was detected in treated sludge after thickening and anaerobic digestion, whereas viral RNA was completely eliminated from sludge only when thermal hydrolysis was applied. Finally, co-analysis of SARS-CoV-2 and F-specific RNA bacteriophages was done in the same water and sludge samples in order to investigate the potential use of these bacteriophages as indicators of SARS-CoV-2 fate and reduction along the wastewater treatment.

Identifiants

pubmed: 34330027
pii: S0043-1354(21)00633-3
doi: 10.1016/j.watres.2021.117435
pmc: PMC8280618
pii:
doi:

Substances chimiques

RNA, Viral 0
Sewage 0
Waste Water 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117435

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Références

Parasitol Res. 2021 Dec;120(12):4167-4188
pubmed: 33409629
Genes (Basel). 2020 Oct 12;11(10):
pubmed: 33053675
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Sci Total Environ. 2020 Aug 15;730:138875
pubmed: 32371231
Sci Total Environ. 2021 Jun 10;772:145268
pubmed: 33556806
Water Res. 2020 Aug 15;181:115942
pubmed: 32425251
PLoS One. 2017 Jan 18;12(1):e0170199
pubmed: 28099518
Appl Environ Microbiol. 2010 Mar;76(5):1388-94
pubmed: 20061455
Sci Total Environ. 2021 Jun 25;775:145790
pubmed: 33618308
Sci Total Environ. 2020 Dec 20;749:141364
pubmed: 32836117
Sci Total Environ. 2005 Mar 1;339(1-3):1-18
pubmed: 15740754
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Environ Int. 2020 Oct;143:105962
pubmed: 32711332
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Environ Sci Technol. 2013 Feb 19;47(4):1945-51
pubmed: 23346855
Appl Environ Microbiol. 2021 Mar 11;87(7):
pubmed: 33483313
Int J Hyg Environ Health. 2021 Apr;233:113692
pubmed: 33592569
Lett Appl Microbiol. 2011 Apr;52(4):386-92
pubmed: 21272046
Sci Total Environ. 2021 Jan 10;751:141750
pubmed: 32861187
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1387-1394.e2
pubmed: 32534042
J Am Med Assoc. 1957 Jun 22;164(8):836-47
pubmed: 13428556
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Emerg Infect Dis. 2020 Aug;26(8):1920-1922
pubmed: 32421494
Sci Total Environ. 2020 Dec 1;746:141326
pubmed: 32768790
J Environ Chem Eng. 2020 Oct;8(5):104429
pubmed: 32895629
Clin Infect Dis. 2021 Oct 5;73(7):e1487-e1488
pubmed: 33043972
Euro Surveill. 2020 Dec;25(50):
pubmed: 33334397
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):533-534
pubmed: 32246939
Chem Eng J. 2021 Jul 1;415:129039
pubmed: 33642938
Cell Rep Med. 2020 Sep 22;1(6):100098
pubmed: 32904687
Sci Total Environ. 2020 Sep 20;736:139652
pubmed: 32464333
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
Ann Intern Med. 2020 Dec 15;173(12):974-980
pubmed: 32870707
Sci Total Environ. 2020 Oct 1;737:140405
pubmed: 32783878
Sci Total Environ. 2020 Nov 15;743:140621
pubmed: 32758821
Process Saf Environ Prot. 2020 Nov;143:196-203
pubmed: 32834559
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
Aliment Pharmacol Ther. 2020 Oct;52(8):1276-1288
pubmed: 32852082
Nat Biotechnol. 2020 Oct;38(10):1164-1167
pubmed: 32948856

Auteurs

Albert Serra-Compte (A)

Cetaqua, Water Technology Centre, Cornellà de Llobregat, Spain. Electronic address: albert.serra@cetaqua.com.

Susana González (S)

Cetaqua, Water Technology Centre, Cornellà de Llobregat, Spain.

Marina Arnaldos (M)

Cetaqua, Water Technology Centre, Cornellà de Llobregat, Spain.

Sabrina Berlendis (S)

Suez, Centre International de Recherche sur l'Eau et l'Environnement (CIRSEE), Le Pecq, France.

Sophie Courtois (S)

Suez, Centre International de Recherche sur l'Eau et l'Environnement (CIRSEE), Le Pecq, France.

Jean Francois Loret (JF)

Suez, Centre International de Recherche sur l'Eau et l'Environnement (CIRSEE), Le Pecq, France.

Olivier Schlosser (O)

Suez, Centre International de Recherche sur l'Eau et l'Environnement (CIRSEE), Le Pecq, France.

Adela M Yáñez (AM)

Labaqua, Alicante, Spain.

Elena Soria-Soria (E)

Labaqua, Alicante, Spain.

Mariana Fittipaldi (M)

Labaqua, Alicante, Spain.

Gemma Saucedo (G)

Aigües de Barcelona, Barcelona, Spain.

Anna Pinar-Méndez (A)

Aigües de Barcelona, Barcelona, Spain.

Miquel Paraira (M)

Aigües de Barcelona, Barcelona, Spain.

Belén Galofré (B)

Aigües de Barcelona, Barcelona, Spain.

Juan M Lema (JM)

CRETUS Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Sabela Balboa (S)

CRETUS Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Miguel Mauricio-Iglesias (M)

CRETUS Institute, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Albert Bosch (A)

University of Barcelona, Barcelona, Spain.

Rosa M Pintó (RM)

University of Barcelona, Barcelona, Spain.

Isabelle Bertrand (I)

University of Lorraine Lorraine, CNRS, LCPME, Nancy, France.

Christophe Gantzer (C)

University of Lorraine Lorraine, CNRS, LCPME, Nancy, France.

Carlos Montero (C)

Cetaqua, Water Technology Centre, Cornellà de Llobregat, Spain.

Xavier Litrico (X)

Suez Groupe, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH